In a world first, a judge of the Federal Court of Australia has found that artificial intelligence (AI) is capable of being an “inventor” for the purposes of the Australian patent regime.
This is one more chapter in the global debate as to whether patent law and policy should adapt to recognise the changing innovation landscape. This decision is one of a series of test cases globally regarding AI “inventors” on the current state of patent law in certain jurisdictions.
The confirmation that, in Australia, AI can be “inventors” under our existing regime (subject to any appeal decision) is contrary to the position in the UK, EPO and USA, where an inventor must be a natural person.
Background
An artificial intelligence system, known as DABUS (or device for the autonomous bootstrapping of unified sentience), had been named as the inventor by the Applicant, Dr Thaler, on a PCT application designating Australia. The alleged invention was the output of DABUS’ various products and methods directed at an improved fractal container.
DABUS had been named as the inventor because the Patent Regulations require, in relation to a PCT Application, the Applicant to name the “inventor of the invention to which the application relates”.
The Deputy Commissioner of Patents (Commissioner) had rejected the application because the application did not name a human inventor. The Commissioner was of the view that the ordinary meaning of “inventor” (which is not defined in the Patents Act) was “inherently human”, and that naming AI as the inventor was incompatible with section 15 of the Patents Act, which provides:
a patent for an invention may only be granted to a person who:
(a) is the inventor; or
(b) would, on the grant of a patent for the invention, be entitled to have the patent assigned to the person; or
(c) derives title to the invention from the inventor or a person mentioned in paragraph (b); or
(d) is the legal representative of a deceased person mentioned in paragraph (a), (b) or (c).
In particular, the Commissioner said that in relation to:
Dr Thaler sought judicial review of the Commissioner’s decision.
The Decision
Beach J found that there was “no specific provision [in the Patents Act] that expressly refutes the proposition that an artificial intelligence system can be an inventor”, and in such circumstances, AI can be an inventor.
While the Commissioner of Patents sought to emphasise the dictionary definitions of “inventor” (given that “inventor” is not defined in the Act), his Honour was not persuaded. He said, having regard to the evolving nature of patentable inventions and their creators that, rather than “resort to old millennium usages of that word,…[he] need[ed] to grapple with the underlying idea, recognising the evolving nature of patentable inventions and their creators. We are both created and create. Why cannot our own creations also create”?.
To this end, his Honour acknowledged the extensive role of AI in pharmaceutical research, as an example of its inventive and technical contribution, which indicated that a narrow view of “inventor” should not be taken.
While “inventor”, in the same way that agent nouns like “computer” may have originally only been used to describe humans, when only humans could make inventions, they are now apt to describe machines that carry out the same function, he said.
In such circumstances, there is no basis to exclude AI from being an “inventor” within the meaning of the Patents Act, and to “preclude a class of otherwise patentable inventions from patentability on the basis of an exclusion that is not apparent from the express words of the Act. Indeed, that would be the antithesis of promoting innovation”.
As to the Commissioner’s arguments pertaining to section 15 of the Act, his Honour said that he found the Commissioner’s reliance on thus section “curious”, because the application only at the formalities stage, which simply required the “inventor” to be named, and nowhere near the stage of grant (which section 15 contemplates).
Regardless, his Honour considered section 15 of the Act. He said that, in principle, Dr Thaler is capable of being entitled to be granted a patent in relation to an invention made by AI such as DABUS under at least sections 15(1)(c) and possibly section 15(1)(b).
As to section 15(1)(b), his Honour said Dr Thaler could bring himself within section 15(1)(b). He said that this section deals with a future conditional, and that it does not require the existence of an inventor at all – all that is required is that he is entitled to have the patent assigned to him in the even there is a grant.
As to section 15(1)(c), he said Dr Thaler prima facie fell within this section, because he has derived title to the invention from DABUS. Despite DABUS not being a legal person that cannot legally assign the invention, title can still be derived from DABUS by reason of his possession of DABUS, his ownership of the copyright in the source code of DABUS, and his ownership and possession of the compute on which it resides.
Given the global significance of this issue and the contrary position of the Australian Federal Court to other courts around the world, we await with interest to see if the Commissioner of Patents appeals the decision to the Full Federal Court.